Oklahoma City, OK, United States of America

Sevim Manolya Hatipoglu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: University of Oklahoma. Active years: 2022-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sevim Manolya Hatipoglu: Innovator in Pharmaceutical Compositions

Introduction

Sevim Manolya Hatipoglu is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug compositions that enhance the solubility of poorly soluble drugs. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Hatipoglu holds 2 patents related to nanocrystal microparticles of poorly soluble drugs. His latest patents focus on microparticulate drug compositions that comprise nanocrystals of poorly soluble drugs combined with a carrier. These patents also disclose pharmaceutical compositions that include these microparticulate drug compositions. Furthermore, the patents detail methods of preparing and using these innovative drug compositions, which have the potential to improve drug delivery and efficacy.

Career Highlights

Sevim Manolya Hatipoglu is affiliated with the University of Oklahoma, where he continues to engage in research and development in the pharmaceutical field. His work is characterized by a commitment to finding solutions for challenges faced in drug solubility and delivery.

Collaborations

Hatipoglu collaborates with esteemed colleagues such as Lucila Garcia-Contreras and Doris Manglaracina Benbrook. These collaborations enhance the research efforts and contribute to the advancement of pharmaceutical sciences.

Conclusion

Sevim Manolya Hatipoglu is a prominent inventor whose work in pharmaceutical compositions is paving the way for innovative solutions in drug delivery. His contributions are vital to the ongoing development of effective treatments for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…